0001493152-23-001416.txt : 20230113 0001493152-23-001416.hdr.sgml : 20230113 20230113161525 ACCESSION NUMBER: 0001493152-23-001416 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230113 FILED AS OF DATE: 20230113 DATE AS OF CHANGE: 20230113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morse Robert A. Jr. CENTRAL INDEX KEY: 0001960049 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 23528937 MAIL ADDRESS: STREET 1: 711 STEWART AVENUE STREET 2: SUITE 200 CITY: GARDEN CITY STATE: NY ZIP: 11530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 BUSINESS PHONE: (215) 345-0919 MAIL ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 3 1 ownership.xml X0206 3 2023-01-13 0 0000868278 ProPhase Labs, Inc. PRPH 0001960049 Morse Robert A. Jr. 711 STEWART AVENUE, SUITE 200 GARDEN CITY NY 11530 0 1 0 0 Controller Stock Option (Right to Buy) 12.01 2029-10-09 Common Stock, par value $0.0005 50000 D The option vests over a three year period, with 25% vesting on the date of grant and 25% vesting on each anniversary thereafter, subject to the Reporting Person's continued service through each vesting date. /s/ Robert A. Morse, Jr. 2023-01-13